Fig. 1 · Structure
Documents & Downloads
KM-233
Chemotherapeutic Agent
KM-233 is a classical cannabinoid that targets the CB2 receptors with a selective affinity, demonstrating effective blood-brain barrier penetration. This compound has shown significant efficacy in reducing U87 glioma tumor burden, making it a valuable tool for glioma research and the study of cannabinoid-based therapies in oncology. Its unique profile positions KM-233 as a promising chemotherapeutic agent for further investigation in cancer treatment protocols.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 628263-22-9 |
| Applications | Chemotherapeutic Agent |
| Formula | C25H30O2 |
| Molecular Weight | 362.50 |
| SMILES | OC1=CC(C(C2=CC=CC=C2)(C)C)=CC3=C1[C@]4([H])CC(C)=CC[C@]4(C(C)(O3)C)[H] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.